Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications
J Gynecol Oncol. 2024 Mar;35(2):e48. doi: 10.3802/jgo.2024.35.e48.NO ABSTRACTPMID:38499045 | PMC:PMC10948994 | DOI:10.3802/jgo.2024.35.e48 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Munetaka Takekuma Source Type: research
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
CONCLUSION: Real-world data suggest that many healthcare professionals still do not easily prescribe HRT for gynecological cancer survivors and BRCA mutation carriers after RRSO. Further efforts are required to implement the use of HRT in clinical practice and to support both clinicians in recommending HRT and patients in accepting it.PMID:38497108 | DOI:10.3802/jgo.2024.35.e70 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Innocenza Palaia Giuseppe Caruso Violante Di Donato Camilla Turetta Antonella Savarese Giorgia Perniola Roberta Gallo Andrea Giannini Vanda Salutari Giorgio Bogani Federica Tomao Diana Giannarelli Gabriella Gentile Angela Musella Ludovico Muzii Sandro Pig Source Type: research
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study
CONCLUSION: In patients with clinically early-stage EOC with serous histology, lymphadenectomy was associated with survival benefits. Considering its potential harm, lymphadenectomy should be performed according to histologic subtype and subsequent chemotherapy in patients with clinically early-stage EOC.TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0007309.PMID:38497109 | DOI:10.3802/jgo.2024.35.e75 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Eun Jung Yang A Jin Lee Woo Yeon Hwang Suk-Joon Chang Hee Seung Kim Nam Kyeong Kim Yeorae Kim Tae Wook Kong Eun Ji Lee Soo Jin Park Joo-Hyuk Son Dong Hoon Suh Dong Hee Son Seung-Hyuk Shim Source Type: research
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications
J Gynecol Oncol. 2024 Mar;35(2):e48. doi: 10.3802/jgo.2024.35.e48.NO ABSTRACTPMID:38499045 | PMC:PMC10948994 | DOI:10.3802/jgo.2024.35.e48 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Munetaka Takekuma Source Type: research
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
CONCLUSION: Real-world data suggest that many healthcare professionals still do not easily prescribe HRT for gynecological cancer survivors and BRCA mutation carriers after RRSO. Further efforts are required to implement the use of HRT in clinical practice and to support both clinicians in recommending HRT and patients in accepting it.PMID:38497108 | DOI:10.3802/jgo.2024.35.e70 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Innocenza Palaia Giuseppe Caruso Violante Di Donato Camilla Turetta Antonella Savarese Giorgia Perniola Roberta Gallo Andrea Giannini Vanda Salutari Giorgio Bogani Federica Tomao Diana Giannarelli Gabriella Gentile Angela Musella Ludovico Muzii Sandro Pig Source Type: research
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study
CONCLUSION: In patients with clinically early-stage EOC with serous histology, lymphadenectomy was associated with survival benefits. Considering its potential harm, lymphadenectomy should be performed according to histologic subtype and subsequent chemotherapy in patients with clinically early-stage EOC.TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0007309.PMID:38497109 | DOI:10.3802/jgo.2024.35.e75 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Eun Jung Yang A Jin Lee Woo Yeon Hwang Suk-Joon Chang Hee Seung Kim Nam Kyeong Kim Yeorae Kim Tae Wook Kong Eun Ji Lee Soo Jin Park Joo-Hyuk Son Dong Hoon Suh Dong Hee Son Seung-Hyuk Shim Source Type: research
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications
J Gynecol Oncol. 2024 Mar;35(2):e48. doi: 10.3802/jgo.2024.35.e48.NO ABSTRACTPMID:38499045 | PMC:PMC10948994 | DOI:10.3802/jgo.2024.35.e48 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Munetaka Takekuma Source Type: research
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
CONCLUSION: Real-world data suggest that many healthcare professionals still do not easily prescribe HRT for gynecological cancer survivors and BRCA mutation carriers after RRSO. Further efforts are required to implement the use of HRT in clinical practice and to support both clinicians in recommending HRT and patients in accepting it.PMID:38497108 | DOI:10.3802/jgo.2024.35.e70 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Innocenza Palaia Giuseppe Caruso Violante Di Donato Camilla Turetta Antonella Savarese Giorgia Perniola Roberta Gallo Andrea Giannini Vanda Salutari Giorgio Bogani Federica Tomao Diana Giannarelli Gabriella Gentile Angela Musella Ludovico Muzii Sandro Pig Source Type: research
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study
CONCLUSION: In patients with clinically early-stage EOC with serous histology, lymphadenectomy was associated with survival benefits. Considering its potential harm, lymphadenectomy should be performed according to histologic subtype and subsequent chemotherapy in patients with clinically early-stage EOC.TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0007309.PMID:38497109 | DOI:10.3802/jgo.2024.35.e75 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Eun Jung Yang A Jin Lee Woo Yeon Hwang Suk-Joon Chang Hee Seung Kim Nam Kyeong Kim Yeorae Kim Tae Wook Kong Eun Ji Lee Soo Jin Park Joo-Hyuk Son Dong Hoon Suh Dong Hee Son Seung-Hyuk Shim Source Type: research
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications
J Gynecol Oncol. 2024 Mar;35(2):e48. doi: 10.3802/jgo.2024.35.e48.NO ABSTRACTPMID:38499045 | PMC:PMC10948994 | DOI:10.3802/jgo.2024.35.e48 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Munetaka Takekuma Source Type: research
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
CONCLUSION: Real-world data suggest that many healthcare professionals still do not easily prescribe HRT for gynecological cancer survivors and BRCA mutation carriers after RRSO. Further efforts are required to implement the use of HRT in clinical practice and to support both clinicians in recommending HRT and patients in accepting it.PMID:38497108 | DOI:10.3802/jgo.2024.35.e70 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Innocenza Palaia Giuseppe Caruso Violante Di Donato Camilla Turetta Antonella Savarese Giorgia Perniola Roberta Gallo Andrea Giannini Vanda Salutari Giorgio Bogani Federica Tomao Diana Giannarelli Gabriella Gentile Angela Musella Ludovico Muzii Sandro Pig Source Type: research
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study
CONCLUSION: In patients with clinically early-stage EOC with serous histology, lymphadenectomy was associated with survival benefits. Considering its potential harm, lymphadenectomy should be performed according to histologic subtype and subsequent chemotherapy in patients with clinically early-stage EOC.TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0007309.PMID:38497109 | DOI:10.3802/jgo.2024.35.e75 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Eun Jung Yang A Jin Lee Woo Yeon Hwang Suk-Joon Chang Hee Seung Kim Nam Kyeong Kim Yeorae Kim Tae Wook Kong Eun Ji Lee Soo Jin Park Joo-Hyuk Son Dong Hoon Suh Dong Hee Son Seung-Hyuk Shim Source Type: research
Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications
J Gynecol Oncol. 2024 Mar;35(2):e48. doi: 10.3802/jgo.2024.35.e48.NO ABSTRACTPMID:38499045 | DOI:10.3802/jgo.2024.35.e48 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Munetaka Takekuma Source Type: research
Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey
CONCLUSION: Real-world data suggest that many healthcare professionals still do not easily prescribe HRT for gynecological cancer survivors and BRCA mutation carriers after RRSO. Further efforts are required to implement the use of HRT in clinical practice and to support both clinicians in recommending HRT and patients in accepting it.PMID:38497108 | DOI:10.3802/jgo.2024.35.e70 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Innocenza Palaia Giuseppe Caruso Violante Di Donato Camilla Turetta Antonella Savarese Giorgia Perniola Roberta Gallo Andrea Giannini Vanda Salutari Giorgio Bogani Federica Tomao Diana Giannarelli Gabriella Gentile Angela Musella Ludovico Muzii Sandro Pig Source Type: research
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study
CONCLUSION: In patients with clinically early-stage EOC with serous histology, lymphadenectomy was associated with survival benefits. Considering its potential harm, lymphadenectomy should be performed according to histologic subtype and subsequent chemotherapy in patients with clinically early-stage EOC.TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0007309.PMID:38497109 | DOI:10.3802/jgo.2024.35.e75 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 18, 2024 Category: OBGYN Authors: Eun Jung Yang A Jin Lee Woo Yeon Hwang Suk-Joon Chang Hee Seung Kim Nam Kyeong Kim Yeorae Kim Tae Wook Kong Eun Ji Lee Soo Jin Park Joo-Hyuk Son Dong Hoon Suh Dong Hee Son Seung-Hyuk Shim Source Type: research
